These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34205940)

  • 1. DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination.
    Casucci G; Acanfora D
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34205940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
    Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH
    J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
    Sønderskov KM; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
    Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
    Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.
    Folegatti PM; Jenkin D; Morris S; Gilbert S; Kim D; Robertson JS; Smith ER; Martin E; Gurwith M; Chen RT;
    Vaccine; 2022 Aug; 40(35):5248-5262. PubMed ID: 35715352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
    Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
    Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
    [No Abstract]   [Full Text] [Related]  

  • 9. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen.
    Soltani Hekmat A; Javanmardi K
    Biomed Res Int; 2021; 2021():7702863. PubMed ID: 34734086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
    Jeon M; Kim J; Oh CE; Lee JY
    J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2.
    Tølbøll Sørensen AL; Rolland M; Hartmann J; Harboe ZB; Roed C; Jensen TØ; Kolte L; El Fassi D; Hillingsø J; Radziwon-Balicka A; Soyka RS; Hansen K; Kirkby N; Goetze JP; Gybel-Brask M; Leinøe EB; Hvas AM; Kampmann P; Stensballe J
    Blood Adv; 2021 Jun; 5(12):2569-2574. PubMed ID: 34137813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.
    Song JY; Cheong HJ; Kim SR; Lee SE; Kim SH; Noh JY; Yoon YK; Choi WS; Park DW; Sohn JW; Kim WJ; Kim MJ
    J Korean Med Sci; 2021 Apr; 36(15):e110. PubMed ID: 33876589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia.
    De Michele M; Iacobucci M; Chistolini A; Nicolini E; Pulcinelli F; Cerbelli B; Merenda E; Schiavo OG; Sbardella E; Berto I; Petraglia L; Caracciolo N; Chiara M; Truglia S; Toni D
    Nat Commun; 2021 Aug; 12(1):4663. PubMed ID: 34341358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.
    Singh A; Bharadwaj SJ; Chirayath AG; Ganguly S
    J Cosmet Dermatol; 2022 Jun; 21(6):2311-2314. PubMed ID: 35348281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.
    Žagar T; Hlača N; Brajac I; Prpić-Massari L; Peternel S; Kaštelan M
    Br J Dermatol; 2022 Mar; 186(3):e110. PubMed ID: 34817862
    [No Abstract]   [Full Text] [Related]  

  • 17. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.
    Majid I; Mearaj S
    Dermatol Ther; 2021 Nov; 34(6):e15146. PubMed ID: 34590397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Quantitative Benefit-Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy.
    Palladino R; Ceriotti D; De Ambrosi D; De Vito M; Farsoni M; Seminara G; Barone-Adesi F
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34201330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature.
    Moslemi M; Ardalan M; Haramshahi M; Mirzaei H; Sani SK; Dastgir R; Dastgir N
    BMC Infect Dis; 2022 Mar; 22(1):217. PubMed ID: 35241013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vocal fold paralysis following first dose of Oxford-AstraZeneca coronavirus disease 2019 vaccine.
    Jama GM; Amin M; Hassaan A; Kaddour H
    J Laryngol Otol; 2022 May; 136(5):466-468. PubMed ID: 35510490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.